“Lobbyists expecting a more conventional pick to lead the government’s $3 trillion health agency than Robert F. Kennedy Jr., the brash contrarian President-elect Donald Trump named on Thursday to take charge, are plotting how to stop the Senate from confirming him,” Politico reports. “They’re also currying favor in case they can’t.” New York Times: Kennedy’s views mix mistrust of business with unfounded health claims. Wall Street Journal: How radical can RFK Jr.